Lipid and lipoprotein levels in normal and complicated pregnancies;Změny lipidü a lipoproteinü provázejí cí fyziologická a riziková těhotenství

Ceska Gynekologie

Volumn 78, Issue 5, 2013, Pages 412-419

  Kokrdova Z ^a   Kostal M ^b  

^a Pardubice Regional Hospital   (Czech Republic)

^b UNIVERSITY OF PARDUBICE   (Czech Republic)

Author keywords

Hyperlipidaemia; Insulin resistance; Metabolic syndrome; Pregnancy

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN;

ADULT; BLOOD; FEMALE; HUMAN; METABOLIC SYNDROME X; PREGNANCY; PREGNANCY COMPLICATION;

ADULT; CHOLESTEROL, HDL; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; METABOLIC SYNDROME X; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84890479324     PISSN: 12107832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Alberti, KG., Eckel, RH., Grundy, SM., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation task force on epidemiology and prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the study of Obesity. Circulation, 2009, 120(16), p. 1640-1645.
2. Ben-Haroush, A., Yogev, Y., Hod, M. Epidemiology of gesta tional diabetes mellitus and its association with type 2 diabetes. Diabet Med, 2004, 21(2), p. 103-113.
3. Dunaif, A. Insulin resistence and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev, 1997, 18(6), p. 774-800.
4. Gunderson, EP. Prospective evidence that lactation protects against cardiovascular disease in women. Am J Obstet Gynecol, 2009, 200(2): p. 119-120.
5. Jimenez, DM., Pocovi, M., Ramon-Cajal, J., et al. Longitudinal study of plasma lipids and lipoprotein cholesterol in normal pregnancy and puerperium. Gynecol Obstet Invest, 1988, 25(3), p. 158-164.
6. Knopp, RH., Bergelin, RO., Wahl, PW., et al. Population-based lipoprotein lipid references values for pregnant women compared to nonpregnant women classified by sex hormone usage. Am J Obstet Gynecol, 1982, 143(6), p. 626-437.
7. Korhonen, S., Hippelainen, M., Niskanen, L., et al. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study. Am J Obstet Gynecol, 2001, 184, p. 289-296.
8. Lewis, CE., Funkhouser, E., Raczynski, JM., et al. Adverse effect of pregnancy on high density lipoprotein (HDL) cholesterol in young adult women. The CARDIA study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol, 1996, 144(3), p. 247-254.
9. Malik, S., Budoff, MJ., Katz, R., et al. Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multi-ethnic study of atherosclerosis. Diabetes Care, 2011, 34(10), p. 2285-2290.
10. Mazurkiewicz, JC., Watts, GF., Warburton, FG., et al. Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patients. J Clin Pathol, 1994, 47(8), p. 728-731.
11. McNamara, JR., Campos, H., Ordovas, JM., et al. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham offspring study. Arteriosclerosis, 1987, 7(5), p. 483-490.
12. McNamara, JR., Jenner, JL., Li, Z., et al. Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Tromb, 1992, 12(11), p. 1284-1290.
13. Piechota, W., Staszewski, A. Refecence ranges of lipids and apolipoproteins in pregnancy. Europ J Obstet Gynecol Reprod Biol, 1992, 45(1), p. 27-35.
14. Reaven, GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 1988, 37(12), p. 1595-1607.
15. Rosolova, H. Současne farmakoterapeuticke možnosti metabolickeho syndromu inzulinove rezistence. Remedia, 2004, 14, s. 307-313.
16. Rybka, J. Trnita cesta metabolickeho syndromu prosadit se v praxi. Vnitř Lek, 2010, 56(7), s. 727-735.
17. Sattar, N., Gaw, A., Scherbakova, O., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in West of Scotland Coronary Prevention Study. Circulation, 2003, 108(4), p. 414-419.
18. Sattar, N., Greer, IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ, 2002, 325(7356), p. 157-160.
19. Sattar, N., Greer, IA., Louden, J., et al. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. J Clin Endocrinol Metab, 1997, 82(8), p. 2483-2491.
20. Taylor, AE. Understanding the underlying metabolic abnormalities of polycystic ovary syndrome and their implications. Am J Obstet Gynecol, 1998, 179, p. 94S-100S.
21. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation, 2002, 106(25), p. 3143-3421.